1. Home
  2. BNKK vs AIMD Comparison

BNKK vs AIMD Comparison

Compare BNKK & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BNKK

Bonk Inc.

N/A

Current Price

$1.08

Market Cap

9.4M

ML Signal

N/A

Logo Ainos Inc.

AIMD

Ainos Inc.

N/A

Current Price

$0.62

Market Cap

10.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNKK
AIMD
Founded
2018
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4M
10.6M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
BNKK
AIMD
Price
$1.08
$0.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 96.6K
28.4K
Earning Date
11-18-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $2,117,309.00
$124,157.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
201.63
★ 498.95
52 Week Low
$0.90
$0.68
52 Week High
$155.05
$3.88

Technical Indicators

Market Signals
Indicator
BNKK
AIMD
Relative Strength Index (RSI) 38.80 15.87
Support Level $0.91 N/A
Resistance Level $1.47 $1.63
Average True Range (ATR) 0.11 0.11
MACD -0.01 -0.02
Stochastic Oscillator 40.91 15.04

Price Performance

Historical Comparison
BNKK
AIMD

About BNKK Bonk Inc.

Bonk Inc provides over-the-counter products and consumer products in the United States. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It sells its products through direct customers, distributors, retailers, and e-commerce websites. The company generates revenue through various channels, its primary sales include nostingz suncare products which are sold through e-commerce platforms, licensing revenues from Photocil and sales of the Safety Shot Beverage. The company has two reportable segments: the dietary and energy beverage business and digital assets, consisting of investing for growth in the appreciation of the asset. It derives the majority of the revenue from the dietary and energy beverage segment.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Share on Social Networks: